[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82906]], camposKey:1129-2369 2024-12-01 Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010¿2020 surveillance-based study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88925]], camposKey:1351-5101 2024-12-01 Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza¿Response00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88926]], camposKey:2045-2322 2024-12-01 Systemic inflammation, oxidative damage and neurocognition predict telomere length in a transdiagnostic sample stratified by global DNA methylation levels00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87383]], camposKey:2044-6055 2024-01-01 Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites. Nested case-control analysis of the immunization-associated risk: A study protocol. , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87384]], camposKey:1351-5101 2024-01-01 Incidence and prevalence of headache in influenza: A 2010-2021 surveillance-based study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87382]], camposKey:0037-8682 2023-01-01 Acceptability of short message service (SMS) as a tool for malaria treatment adherence in the Brazilian Amazon: a qualitative study , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87379]], camposKey:1096-6218 2023-01-01 Barriers of Access to Opioid Medicines within the Context of Palliative Care in Latin America: The Perception of Health Professionals199209, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87381]], camposKey:2199-1154 2023-01-01 Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase263270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87380]], camposKey:0924-9338 2022-01-01 MICEmi: A method to identify cognitive endophenotypes of mental illnesses , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87378]], camposKey:2168-6203 2022-01-01 Mortality in Persons With Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder A Systematic Review and Meta-analysis , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87377]], camposKey:1475-2875 2022-01-01 Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87376]], camposKey:0264-410X 2021-01-01 Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviewsB12B26, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87375]], camposKey:0114-5916 2021-01-01 Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and Principles10851098, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87374]], camposKey:0031-6970 2021-01-01 Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase15131521, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87371]], camposKey:0031-6970 2019-01-01 Amyotrophic lateral sclerosis associated with statins. A disproportionality analysis of the WHO Program for International Drug Monitoring database (VigiBase)587589, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87372]], camposKey:2574-3805 2019-01-01 Association of Anorexia Nervosa With Risk of Cancer A Systematic Review and Meta-analysis , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87373]], camposKey:0273-2300 2019-01-01 Cataracts and statins. A disproportionality analysis using data from VigiBase , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87369]], camposKey:1888-9891 2018-01-01 Trazodone utilization among the elderly in Spain. A population based study208215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87370]], camposKey:2215-0374 2018-01-01 Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases824835, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87366]], camposKey:2046-4053 2017-01-01 Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87367]], camposKey:2046-4053 2017-01-01 Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87365]], camposKey:2046-4053 2017-01-01 Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87368]], camposKey:1932-6203 2017-01-01 The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87362]], camposKey:1549-1277 2016-01-01 Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87364]], camposKey:2173-9110 2016-01-01 Future Perspective of Pharmacoepidemiology in the "Big Data Era" and the Growth of Information Sources , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88927]], camposKey:1135-5727 2016-01-01 Future perspective of pharmacoepidemiology in the "big data era" and the growth of information sources Perspectiva futura de la farmacoepidemiología en la era del "big data" y la expansión de las fuentes de información00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87363]], camposKey:0025-7753 2016-01-01 Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014287292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88928]], camposKey:0300-8932 2015-12-01 Antihypertensive Medication: On the Right Path? Response Prescripción de fármacos antihipertensivos: ¿en el buen camino? Respuesta11911192, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88929]], camposKey:0300-8932 2015-10-01 Use of Antihypertensive Drugs in Spain: National Trends From 2000 to 2012 Uso de medicamentos antihipertensivos en España: tendencias nacionales en el periodo 2000-2012899903, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88930]], camposKey:1135-5727 2015-03-01 Clinical-epidemiological profile of patients initiating intensive statin therapy for the secondary prevention of vascular disease in Spain Perfil clínico-epidemiológico de pacientes que inician terapia intensiva con estatinas para la prevención secundaria de enfermedad vascular en España159171, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87359]], camposKey:0300-8932 2015-01-01 Antihypertensive Medication: On the Right Path? Response11911192, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87360]], camposKey:0025-7753 2015-01-01 Clinical equipoise and systematic reviews of randomized controlled trials496498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87355]], camposKey:1135-5727 2015-01-01 Clinical-Epidemiological Profile of Patients Initiating Intensive Statin Therapy for the Secondary Prevention of Vascular Disease in Spain159171, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88931]], camposKey:1130-6343 2015-01-01 Impact of the economic crisis on the activity of a clinical research ethics committee; response from the Spanish Agency of Medicines and Medical Devices Impacto de la crisis económica en la actividad de un comité ético de investigación clínica; respuesta de la Agencia Española de Medicamentos y Productos sanitarios224225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87356]], camposKey:0025-7753 2015-01-01 Primary prevention of cardiovascular diseases with statins in patients with diabetes285287, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87361]], camposKey:0025-7753 2015-01-01 Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials511519, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87357]], camposKey:1074-2484 2015-01-01 Statins Use and Risk of Cataracts: Firm Conclusions Are Still Far Off344345, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87358]], camposKey:0300-8932 2015-01-01 Use of Antihypertensive Drugs in Spain: National Trends From 2000 to 2012899903, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59309]], camposKey:1022-6877 2014-01-01 A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions174182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87354]], camposKey:0025-7753 2014-01-01 Hepatotoxicity in patients treated with endothelin receptor antagonists: Systematic review and meta-analysis of randomized clinical trials333342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87353]], camposKey:0091-7435 2014-01-01 Progressive chronic kidney disease and dual inhibition of the renin-angiotensin-aldosterone system136136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87351]], camposKey:2173-9110 2014-01-01 Risks of Dual Blockade of the Renin-Angiotensin System Compared with Monotherapy: A Systematic Review and Cumulative Meta-analysis of Randomized Trials and Observational Studies3765, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87352]], camposKey:0031-6970 2014-01-01 Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based study99108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88933]], camposKey:1130-6343 2013-12-17 Ethical and methodological quality of non-interventional post-authorization studies promoted by hospital pharmacy departments Calidad ética y metodológica de los estudios posautorización de tipo observacional promovidos por Servicios de Farmacia Hospitalaria482488, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88932]], camposKey:1130-6343 2013-12-17 Regulatory procedures of non-interventional post-authorization studies in Spain Normativa de los estudios posautorización de tipo observacional en España530533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88934]], camposKey:0300-8932 2013-05-01 Diabetes mellitus and risks of dual blockade of the renin-angiotensin- aldosterone system Diabetes mellitus y riesgos del bloqueo dual del sistema renina-angiotensina-aldosterona412415, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88935]], camposKey:1135-5727 2013-05-01 Trends of use of anxiolytics and hypnotics in Spain from 2000 to 2011 Evolución deluso de medicamentos ansiolíticos e hipnóticos en Españadurante el período 2000-2011247255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87349]], camposKey:0300-8932 2013-01-01 Diabetes Mellitus and Risks of Dual Blockade of the Renin-angiotensin-aldosterone System412415, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87350]], camposKey:1444-0903 2013-01-01 Endothelin receptor antagonists-induced hepatotoxicity609610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87348]], camposKey:1135-5727 2013-01-01 Trends of Use of Anxiolytics and Hypnotics in Spain from 2000 to 2011247255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87347]], camposKey:0025-7753 2012-01-01 Is it necessary to modify the normative of medical research when drugs are not the study objective? Response from the Spanish Agency of Medicines and Health Devices546547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87346]], camposKey:0025-7753 2010-01-01 Non-interventional post-authorisation studies in Spain: Impact of the 2002 regulation423427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3377]], camposKey:0009-9236 2010-01-01 Response to rupatadine and heart rhythm disturbances3738, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40]], camposKey:0009-9236 2009-01-01 Heart Rhythm Disturbances Associated With Rupatadine: A Case Series From the Spanish and Portuguese Pharmacovigilance Systems481484, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3380]], camposKey:0114-5916 2007-01-01 Gynaecomastia associated with proton pump inhibitors: A case series from the Spanish pharmacovigilance system527531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39772]], camposKey:0114-5916 2006-01-01 HMG CoA reductase inhibitors and impotence - Two case series from the Spanish and French drug monitoring systems143149][][com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2818]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2810]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2815]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2814]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2813]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2817]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2812]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2816]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=2811]]][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][]